DCF — NORTH SHORE MEDICAL CENTER
Enterprise Value: $-1.0B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.0B
Enterprise Value
$-313.6M
PV of Cash Flows
$-689.1M
PV of Terminal Value
$-1.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $518.6M | $-64.5M | -12.0% | $-86.4M | $-78.6M |
| Year 2 | $534.2M | $-61.1M | -11.0% | $-83.7M | $-69.1M |
| Year 3 | $550.2M | $-57.4M | -10.0% | $-80.7M | $-60.6M |
| Year 4 | $566.7M | $-56.3M | -10.0% | $-80.3M | $-54.8M |
| Year 5 | $583.7M | $-56.5M | -10.0% | $-81.2M | $-50.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.0B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$503.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12930051119121197
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5